or
forgot password

    • cancer clinical trials in durham, NC

    • Gefitinib (Iressa) and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
    Duke University Medical Center
    Durham, North Carolina 27710
    Myelodysplastic Syndrome
    Phase II Trial of Allovectin-7® for Metastatic Melanoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Melanoma, Metastatic Melanoma, Malignant Melanoma, Skin Cancer
    Genetic Study of Young Patients With Colorectal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Colorectal Cancer
    Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Malnutrition, Prostate Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Breast Cancer
    ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer
    Abraxis Bioscience, Inc.
    Durham, North Carolina 27703
    Breast Neoplasms, Metastases, Neoplasm
    Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer
    Abraxis Bioscience, Inc
    Durham, North Carolina 27703
    Breast Neoplasms, Metastases, Neoplasm
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Duke Cancer Institute
    Durham, North Carolina 27710
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Colorectal Cancer, Diarrhea, Neutropenia
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Duke University Medical Center
    Durham, North Carolina 27710
    Ovarian Cancer
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Neoplasms, Breast Cancer, Metastasis
    Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Non-Small Cell Lung Cancer
    Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
    Duke University Medical Center
    Durham, North Carolina 27710
    Von Hippel-Lindau Disease, Central Nervous System Capillary Hemangioblastoma, Retinal Capillary Hemangioblastoma
    Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Prostate Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Esophageal Neoplasms, Stomach Neoplasms, Adenocarcinoma
    An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasm
    An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Colonic Neoplasms, Colorectal Neoplasms
    Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    Duke University Medical Center
    Durham, North Carolina 27710
    Multiple Myeloma
    Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Adult Solid Tumor, Protocol Specific
    BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lymphoma
    Study of Karenitecin (BNP1350) in Patients With Brain Tumors
    For Information call 210-614-1701 for a site near you
    Durham, North Carolina 27710
    Brain Neoplasms, Malignant Neoplasms, Brain, Brain Tumors
    Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab
    Duke University Medical Center
    Durham, North Carolina 27710
    Non-Hodgkin's Lymphoma
    Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
    Duke University Medical Center
    Durham, North Carolina 27710
    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Oligoastrocytoma
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Neutropenia, Sarcoma
    A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Sepsis, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Infection
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Vulvar Cancer
    Survival TRaining for ENhancing Total Health (STRENGTH)
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Depression, Weight Changes
    Anidulafungin in Treating Immunocompromised Children With Neutropenia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Infection, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician
    Durham, North Carolina
    Carcinoma, Non-Small-Cell Lung
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lymphoma
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lung Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Veterans Affairs Medical Center - Durham
    Durham, North Carolina 27705
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Sarcoma
    Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer
    A Study of ABT-751 in Patients With Colorectal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Colorectal Cancer
    TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
    Duke University Medical Center
    Durham, North Carolina 27710
    Lymphoma, Infection, Leukemia
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Pediatric Hypothalamic Obesity
    Duke University Medical Center
    Durham, North Carolina 27710
    Obesity
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Duke Medical Center Pain Clinic
    Durham, North Carolina 27705
    Pain
    The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
    Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma Multiforme
    Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Colorectal Cancer
    Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Myeloid Leukemia